These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 36305726)

  • 21. Targeting ATR in Cancer Medicine.
    Salguero C; Valladolid C; Robinson HMR; Smith GCM; Yap TA
    Cancer Treat Res; 2023; 186():239-283. PubMed ID: 37978140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I.
    Li C; Wang B; Tu J; Liu C; Wang Y; Chen J; Huang Y; Liu B; Yuan X
    Cell Death Dis; 2024 Jul; 15(7):519. PubMed ID: 39033176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic vulnerabilities upon inhibition of DNA damage response.
    Wang C; Tang M; Chen Z; Nie L; Li S; Xiong Y; Szymonowicz KA; Park JM; Zhang H; Feng X; Huang M; Su D; Hart T; Chen J
    Nucleic Acids Res; 2021 Aug; 49(14):8214-8231. PubMed ID: 34320214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATM in DNA repair in cancer.
    Jin MH; Oh DY
    Pharmacol Ther; 2019 Nov; 203():107391. PubMed ID: 31299316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer.
    Deng S; Vlatkovic T; Li M; Zhan T; Veldwijk MR; Herskind C
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JAK Inhibition Prevents DNA Damage and Apoptosis in Testicular Ischemia-Reperfusion Injury via Modulation of the ATM/ATR/Chk Pathway.
    Khashab F; Al-Saleh F; Al-Kandari N; Fadel F; Al-Maghrebi M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The development of ataxia telangiectasia mutated kinase inhibitors.
    Andrs M; Korabecny J; Nepovimova E; Jun D; Hodny Z; Moravcova S; Hanzlikova H; Kuca K
    Mini Rev Med Chem; 2014; 14(10):805-11. PubMed ID: 25138084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of small-cell lung cancer associates with STING pathway activation and is enhanced by ATR and TOP1 inhibition.
    Li X; Li Y; Zhao Z; Miao N; Liu G; Deng L; Wei S; Hou J
    Cancer Med; 2023 Feb; 12(4):4864-4881. PubMed ID: 35957613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress.
    Yan S; Sorrell M; Berman Z
    Cell Mol Life Sci; 2014 Oct; 71(20):3951-67. PubMed ID: 24947324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BK Polyomavirus Activates the DNA Damage Response To Prolong S Phase.
    Justice JL; Needham JM; Thompson SR
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31043526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy.
    Chan Wah Hak CML; Rullan A; Patin EC; Pedersen M; Melcher AA; Harrington KJ
    Front Oncol; 2022; 12():971959. PubMed ID: 36106115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted Inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 Modulate Response to X Rays and Protons.
    Bright SJ; Flint DB; Martinus DKJ; Turner BX; Manandhar M; Ben Kacem M; McFadden CH; Yap TA; Shaitelman SF; Sawakuchi GO
    Radiat Res; 2022 Oct; 198(4):336-346. PubMed ID: 35939823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ataxia-telangiectasia mutated and ataxia telangiectasia and Rad3-related kinases as therapeutic targets and stratification indicators for prostate cancer.
    Gulliver C; Hoffmann R; Baillie GS
    Int J Biochem Cell Biol; 2022 Jun; 147():106230. PubMed ID: 35609768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer.
    Nam AR; Jin MH; Park JE; Bang JH; Oh DY; Bang YJ
    Cancer Res Treat; 2019 Jul; 51(3):1167-1179. PubMed ID: 30514066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-cancer immune responses to DNA damage response inhibitors: Molecular mechanisms and progress toward clinical translation.
    Carlsen L; El-Deiry WS
    Front Oncol; 2022; 12():998388. PubMed ID: 36276148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
    Eich M; Roos WP; Nikolova T; Kaina B
    Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
    Cui Y; Palii SS; Innes CL; Paules RS
    Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential DNA Damage Response of Peripheral Blood Lymphocyte Populations.
    Felgentreff K; Schuetz C; Baumann U; Klemann C; Viemann D; Ursu S; Jacobsen EM; Debatin KM; Schulz A; Hoenig M; Schwarz K
    Front Immunol; 2021; 12():739675. PubMed ID: 34594342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-Mercaptoethanol protects against DNA double-strand breaks after kidney ischemia and reperfusion injury through GPX4 upregulation.
    Moon D; Padanilam BJ; Jang HS; Kim J
    Pharmacol Rep; 2022 Oct; 74(5):1041-1053. PubMed ID: 35989399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral DNA replication-dependent DNA damage response activation during BK polyomavirus infection.
    Verhalen B; Justice JL; Imperiale MJ; Jiang M
    J Virol; 2015 May; 89(9):5032-9. PubMed ID: 25694603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.